Scientific leader with expertise in biology, toxicology, and pharmacology, specializing in GLP-compliant research and method development. Proven ability to lead cross-functional teams in regulated environments, ensuring alignment of R&D strategies with organizational objectives. Demonstrated success in driving innovation and quality improvement in laboratory and clinical settings. Extensive experience in consulting, research, and education to advance the development of novel health-related compounds.
Inaugural Croatian Women of Influence Award – Science and Technology Category Zagreb, Croatia • 2016
André Boivin Visiting Professorship Award for Maternal-Fetal Toxicology
Combined Award from Duchenay and the Motherisk Program at The Hospital for Sick Children • 2012
CIHR - CMAJ Top Achievement Award in Health Research • 2012
University of Toronto Fellowship • 2001 – 2003
Hospital for Sick Children Restracomp Grant • 2002-2003
Canadian Institute of Health Research (CIHR) Studentship • 1998-2001
Medical Research Council of Canada (MRC) Studentship • 1995-1997
GLP Study Director and Principal Investigator Training • Society of Quality Assurance • Issued 2022
New York State Department of Health, Certificate of Qualification for
Laboratory Director in Clinical Toxicology and TDM/TOX New York State Department of Health • Issued 2017
Publications specific to nicotine and tobacco: